Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/190602
High-potency ligands for DREADD imaging and activation in rodents and monkeys
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) are a popular chemogenetic technology for manipulation of neuronal activity in uninstrumented awake animals with potential for human applications as well. The prototypical DREADD agonist clozapine N-oxide (CNO) lacks brain entry and converts to clozapine, making it difficult to apply in basic and translational applications. Here we report the development of two novel DREADD agonists, JHU37152 and JHU37160, and the first dedicated 18F positron emission tomography (PET) DREADD radiotracer, [18F]JHU37107. We show that JHU37152 and JHU37160 exhibit high in vivo DREADD potency. [18F]JHU37107 combined with PET allows for DREADD detection in locally-targeted neurons, and at their long-range projections, enabling noninvasive and longitudinal neuronal projection mapping.
Matèries
Matèries (anglès)
Citació
Citació
BONAVENTURA, Jordi, ELDRIDGE, Mark a.g., HU, Feng, GOMEZ, Juan l., SÁNCHEZ SOTO, Marta, ABRAMYAN, Ara m., LAM, Sherry, BOEHM, Matthew a., RUIZ, Christina, FARRELL, Mitchell r., MORENO, Andrea, GALAL FARESS, Islam mustafa, ANDERSEN, Niels, Linm John Y., MOADDEL, Ruin, MORRIS, Patrick j., SHI, Lei, SIBLEY, David r., MAHLER, Stephen v., NABAVI, Sadegh, POMPER, Martin g., BONCI, Antonello, HORTI, Andrew g., RICHMOND, Barry j., MICHAELIDES, Michael. High-potency ligands for DREADD imaging and activation in rodents and monkeys. _Nature Communications_. 2019. Vol. 10. [consulta: 25 de febrer de 2026]. ISSN: 2041-1723. [Disponible a: https://hdl.handle.net/2445/190602]